These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8810733)

  • 1. Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities.
    Maghnie M; Moretta A; Valtorta A; Larizza D; Sayegh M; Greco AM; Castoldi E; Severi F
    Eur J Endocrinol; 1996 Aug; 135(2):198-204. PubMed ID: 8810733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K; Schober E; Birnbacher R; Frisch H
    Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic MRI in the congenital agenesis of the neural pituitary stalk syndrome: the role of the vascular pituitary stalk in predicting residual anterior pituitary function.
    Maghnie M; Genovese E; Villa A; Spagnolo L; Campan R; Severi F
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):281-90. PubMed ID: 8949565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
    Bando H; Yamasaki R; Saito S
    Endocrinol Jpn; 1989 Oct; 36(5):705-20. PubMed ID: 2559840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
    Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients.
    Murray RD; Peacey SR; Rahim A; Toogood AA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):37-44. PubMed ID: 11167924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction.
    Aimaretti G; Bellone S; Bellone J; Chiabotto P; Baffoni C; Corneli G; Origlia C; de Sanctis C; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):287-93. PubMed ID: 10718826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion.
    Martha PM; Blizzard RM; McDonald JA; Thorner MO; Rogol AD
    J Clin Endocrinol Metab; 1988 Sep; 67(3):449-54. PubMed ID: 2900843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities.
    Maghnie M; Triulzi F; Larizza D; Preti P; Priora C; Scotti G; Severi F
    J Clin Endocrinol Metab; 1991 Jul; 73(1):79-83. PubMed ID: 1904454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma GH response to the sequential 3 day administrations of GHRH followed by arginine infusion in patients with idiopathic GH deficiency and normal short children.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Tazawa S; Abe K
    Tohoku J Exp Med; 1993 Feb; 169(2):91-101. PubMed ID: 8236247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL; Wallace WH; Shalet SM
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.